Corcept Therapeutics Incorporated
CORTNASDAQHealthcare● Active
$73.33
+$0.71(+0.98%)
Market Cap$7.9B
P/E Ratio—
52W High$91
52W Low$28.66
Corcept Therapeutics Incorporated (CORT) · Balance Sheet
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · CORT · as of 2026-06-10
Financial statements
Total Assets · Total Liabilities · Equity
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Assets | |||||
| Cash & ST Investments | $0.37B | $0.38B | $0.37B | $0.43B | $0.22B |
| Net Receivables | $0.06B | $0.06B | $0.06B | $0.05B | $0.03B |
| Inventory | $0.01B | $0.01B | $0.01B | $0.01B | $0.00B |
| Total Current Assets | $0.49B | $0.47B | $0.46B | $0.50B | $0.27B |
| PP&E Net | $0.01B | $0.01B | $0.00B | $0.00B | $0.00B |
| Goodwill | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Intangible Assets | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Total Assets | $0.84B | $0.84B | $0.62B | $0.58B | $0.42B |
| Liabilities | |||||
| Short-Term Debt | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Accounts Payable | $0.04B | $0.02B | $0.02B | $0.01B | $0.01B |
| Total Current Liabilities | $0.17B | $0.14B | $0.10B | $0.07B | $0.05B |
| Long-Term Debt | $0.01B | $0.00B | $0.00B | $0.00B | $0.00B |
| Total Liabilities | $0.19B | $0.16B | $0.11B | $0.08B | $0.05B |
| Stockholders Equity | |||||
| Retained Earnings | $0.64B | $0.54B | $0.40B | $0.30B | $0.19B |
| Total Stockholders Equity | $0.65B | $0.68B | $0.51B | $0.50B | $0.38B |
| Total Liab & Equity(computed) | $0.84B | $0.84B | $0.62B | $0.58B | $0.42B |
| Debt Summary | |||||
| Total Debt | $0.01B | $0.01B | $0.00B | $0.00B | $0.00B |
| Net Debt | ($0.11B) | ($0.12B) | ($0.14B) | ($0.07B) | ($0.08B) |
Data source: Financial Modeling Prep · Last updated: 2026-06-10 · USD · B
Explore more Corcept Therapeutics Incorporated data
About Corcept Therapeutics Incorporated (CORT) Balance Sheet
Corcept Therapeutics Incorporated (CORT) balance sheet shows total assets of $0.84B with cash of $0.37B. Total liabilities are $0.19B, total debt $0.01B, and stockholders equity $0.65B.
Frequently asked questions
CORT · 4 questionsCorcept Therapeutics Incorporated has total debt of $0.01B with net debt of ($0.11B).
CORT total debtnet debtdebt to equity
· Source: FMP /stable/balance-sheet-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-10